Aristeidis Vaiopoulos

10PUBLICATIONS
35CO-AUTHORS
PharmacogenomicsMedical mycologyGlycoconjugatesMedical infection agents (incl. prions)Disease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 27, 2025
Long-Term Outcomes of Guselkumab and Risankizumab for the Management of Moderate-to-Severe Psoriasis in the Elderly: Results from a Real-World Retrospective Study.

Ioannis-Alexios Koumprentziotis, Irene Stefanaki, Eleni Routsi

|Sep 19, 2024
Effectiveness and safety of methotrexate in the treatment of mycosis fungoides: Real-world data from a multicentre study.

Vasiliki Nikolaou, Evdoxia Panou, Antonios Tsimpidakis

|Aug 10, 2024
The Effect of 4-Month Treatment with Glycocalyx Dietary Supplement on Endothelial Glycocalyx Integrity and Vascular Function in Patients with Psoriasis.

Ignatios Ikonomidis, Eleni Katsanaki, John Thymis

|Apr 13, 2024
Rotational Thromboelastometry as a Diagnostic Tool for Persistent Infection in Two-Stage Exchange Arthroplasty.

Andreas G Tsantes, Dimitrios V Papadopoulos, Stavros Goumenos

|Feb 10, 2024
Insights, Advantages, and Barriers of Teledermatology vs. Face-to-Face Dermatology for the Diagnosis and Follow-Up of Non-Melanoma Skin Cancer: A Systematic Review.

Georgios Nikolakis, Aristeidis G Vaiopoulos, Ioannis Georgopoulos

|Sep 25, 2023
Real-world data show high efficacy of IL23 inhibitors guselkumab and risankizumab in psoriatic arthritis and difficult-to-treat areas.

Aristeidis G Vaiopoulos, Maria Dalamaga, Pelagia Katsimbri

Pageof 2

Frequent Collaborators

4 joint publications

Ioannis-Alexios Koumprentziotis

3 joint publications

Christos C Zouboulis

2 joint publications

Electra Nicolaidou

2 joint publications

Irene Stefanaki